The ketamine therapy sector is navigating a volatile landscape where high-growth potential meets rigid financial gatekeeping. While the market was valued at $3.41 billion in 2023, many legitimate, licensed clinics struggle to maintain stable credit card processing. Because these facilities often operate in a high-risk category due to the nature of controlled substances and off-label usage, mainstream processors frequently trigger automatic shutdowns, leaving practitioners unable to collect payments for services rendered.
Organic Payment Gateways Targets Ketamine Clinic Payment Instability
A clinic opens, begins treating patients, and suddenly finds its revenue stream severed by a payment processor's automated filter. With the U.S. ketamine therapy market projected to reach significant scale by 2030, Organic Payment Gateways is launching a specialized service to protect these practices from sudden account closures.
Alex Roy, owner of Organic Payment Gateways, notes that the disruption often stems from broad, industry-wide compliance rules that fail to distinguish between ethical medical providers and high-risk merchants. To counter this, the firm conducts manual reviews of a clinic’s business model and licensing to secure underwritten merchant accounts. This approach allows psychiatry-led clinics, infusion centers, and esketamine facilities to maintain payment infrastructure—including in-office terminals and patient portal billing—without overhauling their existing software. By prioritizing direct, human-led support and transparent underwriting, the company aims to provide a reliable alternative for providers who are otherwise sidelined by the automated policies of larger financial platforms.
Comments (0)
No comments yet. Be the first!